H Jules & Company Ltd - pharma in Nagpur, Maharashtra, India. FY 2026 financials & compliance.
CIN U24230MH1991PLC062174 Incorporated 21 June 1991 ROC Nagpur HQ Nagpur, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2023
₹36.88 Cr
▲ 19% YoY
Net profit · FY 2023
₹1.83 Cr
Net margin 5%
EBITDA · FY 2023
₹2.54 Cr
EBITDA margin 6.9%
Authorised capital
₹4 Cr
Registered with MCA
Paid-up capital
₹1.52 Cr
Issued & subscribed
Satisfied charges
₹3.34 Cr
No open charges
Company age
35 yrs
Est. 1991
Directors on board
5
As per MCA filings

About H Jules & Company Ltd

Data last updated:

H Jules & Company Ltd is a public limited company based in Nagpur, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 June 1991 and has been in existence for over 35 years.

The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24230MH1991PLC062174. Its GSTIN is 27AAACH4294A1ZV (Maharashtra). The company holds 3 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹4 Cr and a paid-up capital of ₹1.52 Cr. It was formerly known as H Jules & Company Private Ltd. It is led by directors including Hussain Rafi (Whole-Time Director) and Bhavana (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Room N. 8 Tulsi Park Dabha Ring Road Hajari Pahad, Nagpur, Maharashtra, India – 440013.

As per the financials filed for FY 2023, the company reported a revenue of ₹36.88 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹1.83 Cr (net margin 5%) and EBITDA of ₹2.54 Cr (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 24% over five years.

The company is associated with 1 brand: H Jules and Company. As per MCA filings, the company has satisfied charges of ₹3.34 Cr on record. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website hjules.in.

Company details

CIN U24230MH1991PLC062174
Registration Number 062174
Incorporation Date 21 June 1991
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant

CIN history

H Jules & Company has one previous CIN (Corporate Identification Number): U24230MH2003PTC062174. The current CIN is U24230MH1991PLC062174, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24230MH1991PLC062174Current
U24230MH2003PTC062174Previous

Contact details

H Jules & Company Ltd's registered office is in Nagpur, Maharashtra. Its website is hjules.in. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
  • Registered Address
    Room N. 8 Tulsi Park Dabha Ring Road Hajari Pahad, Nagpur, Maharashtra, India – 440013
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of H Jules & Company Ltd, buy the company report.

Comprehensive company report
H Jules & Company Ltd - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

H Jules & Company operates one associated brand: H Jules and Company. Each brand links to its own profile.

BrandDescriptionWebsite
Global distributor of pharmaceutical APIs, excipients, and formulations for various applications.hjules.in

Business activity

The main business activity of H Jules & Company is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of H Jules & Company Ltd, buy the company report.

Financials of H Jules & Company Ltd

FY 2023 filings available

H Jules & Company Ltd reported revenue of ₹36.88 Cr (up 19% YoY) for FY 2023.

Revenue · FY 2023
₹36.88 Cr ▲ 19%
Net profit · FY 2023
₹1.83 Cr margin 5%
EBITDA · FY 2023
₹2.54 Cr margin 6.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 13%
5 years · compounded
▲ 24%
EBITDA CAGR growth
1 year
▲ 137%
3 years · compounded
▲ 78%
5 years · compounded
▲ 61%

Revenue has grown at a compounded annual rate (CAGR) of 24% over five years, including 19% growth in the latest year. EBITDA rose 137% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue₹36.88 Cr
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.54 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹1.83 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
EBITDA Margin6.9%
Net Profit Margin5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of H Jules & Company Ltd, buy the company report.

Board of directors of H Jules & Company Ltd

H Jules & Company has 5 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Hussain RafiWhole-Time Director01 Jul 20233 Years 4 MonthsCurrent
BhavanaWhole-Time Director13 Nov 20196 Years 11 MonthsCurrent
Naresh Janardan GaikwadWhole-Time Director01 Jul 20233 Years 4 MonthsCurrent
Gajanan Laxmanrao BangadkarWhole-Time Director15 Dec 201114 Years 10 MonthsCurrent
Himanshuranjan Awadeshchandra TiwariDirector01 Jun 20224 Years 5 MonthsCurrent

Peer comparison

H Jules & Company Ltd is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Spectra Therapeutics Private Limited₹37.02 Cr (FY 2025)20.0%Ahmedabad, Gujarat, India
Nexnos Pharma Limited₹36.91 Cr (FY 2025)187.0%Chittorgarh, Rajasthan, India
H Jules & Company Ltdthis company₹36.88 Cr (FY 2023)₹1.83 Cr5%19.0%Nagpur, Maharashtra, India
Biotech Solutions & Pharmaceuticals Limited₹36.57 Cr (FY 2024)23.0%Hyderabad, Telangana, India
Abhinav Biotech Private Limited₹36.48 Cr (FY 2024)39.0%Delhi, India
Rockmed Pharma Private Limited₹36.45 Cr (FY 2024)-28.0%New Delhi, Delhi, India

To see the full peer comparison of H Jules & Company Ltd, buy the company report.

Auditor

H Jules & Company Ltd is audited by Avjeet S Mishra & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
Avjeet S Mishra & Co.FY 2023150852W

Shareholding

The shareholding of H Jules & Company Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of H Jules & Company Ltd, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹3.34 Cr
Breakdown by lending institutions
Bank of Baroda₹3.14 Cr
Union Bank of India₹0.16 Cr
The Maharashtra Financial Corporation₹0.05 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Dec 200290154694Bank of Baroda₹2.81 CrSatisfied
20 Oct 199990153653Bank of Baroda₹10 LakhSatisfied
01 Jun 199990152536Union Bank of India₹16 LakhSatisfied
26 Feb 199390154429The Maharashtra Financial Corporation₹4.5 LakhSatisfied
30 Mar 199290152826Bank of Baroda₹8 LakhSatisfied

To see the full charge records of H Jules & Company Ltd, buy the company report.

Total charge records: 6 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for H Jules & Company Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

H Jules & Company has 3 GST registrations: 1 active and 2 cancelled or inactive.

Total GSTINs
3
Active
1
Cancelled / inactive
2
GSTINStateStatusRegistered on
27AAACH4294A1ZVMaharashtraActive01 Jul 2017

To see the full GST registrations and return filing status of H Jules & Company Ltd, buy the company report.

Recent activity

H Jules & Company Ltd has 23 board changes on record since 2009: 6 appointments and 17 cessations. The latest: Kakasaheb Ramoo Mahadik ceased to be Additional Director on 29 Sep 2025.

AGM
H Jules & Company Ltd last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Kakasaheb Ramoo Mahadik ceased to be Additional Director.
Appointed
Kakasaheb Ramoo Mahadik was appointed as Additional Director.
Ceased
Hussain Rafi ceased to be Additional Director.
Ceased
Naresh Janardan Gaikwad ceased to be Additional Director.
Appointed
Hussain Rafi was appointed as Whole-Time Director.
Appointed
Naresh Janardan Gaikwad was appointed as Whole-Time Director.
Filing
H Jules & Company Ltd has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Nagpur.
Ceased
Himanshuranjan Awadeshchandra Tiwari ceased to be Additional Director.
Appointed
Himanshuranjan Awadeshchandra Tiwari was appointed as Director.
Ceased
Arun Sadashiv Mundhey ceased to be Whole-Time Director.
Charges
A charge registered on 26 Feb 1993 via Charge ID 90154429 with The Maharashtra Financial Corporation was fully satisfied on 07 Jul 2021.

30 earlier events are in the company report.

Frequently asked questions

H Jules & Company is an active public limited company based in Nagpur, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 June 1991 (35+ years old) and is registered under CIN U24230MH1991PLC062174.

H Jules & Company has 5 current directors:

The latest financial statements of H Jules & Company on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of H Jules & Company is 27AAACH4294A1ZV, registered in Maharashtra. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.

The CIN (Corporate Identification Number) of H Jules & Company is U24230MH1991PLC062174. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

H Jules & Company has 4 court cases on record: 3 filed by the company and 1 filed against it.

H Jules & Company was incorporated on 21 June 1991, making it 35+ years old. It is registered with the Registrar of Companies, Nagpur.

The peers of H Jules & Company by revenue are Spectra Therapeutics Private Limited, Nexnos Pharma Limited, Biotech Solutions & Pharmaceuticals Limited, Abhinav Biotech Private Limited, Rockmed Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Kakasaheb Ramoo Mahadik ceased to be Additional Director on 29 Sep 2025. Kakasaheb Ramoo Mahadik was appointed as Additional Director on 01 Apr 2025. Hussain Rafi ceased to be Additional Director on 29 Sep 2023. H Jules & Company has 23 board changes on record in total.

H Jules & Company can be reached through the website hjules.in. Its registered office is in Nagpur, Maharashtra, India.

The registered office of H Jules & Company is at Room N. 8 Tulsi Park Dabha Ring Road Hajari Pahad, Nagpur, Maharashtra, India – 440013.